@entity258 : risk factors for XXXX .

@entity1 @entity323 @entity82 @entity6358 @entity527 @entity258 @entity3327 @entity74 @entity158 @entity3302 @entity5501 @entity1211 @entity130
OBJECTIVE: To evaluate our policy of managing @entity3327 for the success rate of the treatments, potency afterward, complications, and the risk factors responsible for @entity323 in these @entity1 . @entity1 AND METHODS: The study included 50 @entity1 (mean age 37.1 years, range 22-66) with a diagnosis of @entity3327 (1981-1999). Their records were reviewed; 35 @entity1 were available for a long-term evaluation. Factors assessed were the duration of @entity3327 , history of previous recurrent attacks, possible underlying causes (e.g. @entity74 , medications or @entity130 ), relation to sexual stimulation, @entity158 , and any attempt at previous management. A complete blood screen and blood gases were assessed in corporal aspirates. Duplex ultrasonography was used in all @entity323 @entity1 at their follow-up. Early and late complications were reviewed, and @entity1 asked about their erectile function before @entity3327 , and any recurrence. RESULTS: The median (range) duration of @entity3327 was 48 (6-240) h; almost half the @entity1 presented > 48 h after the onset of @entity3327 . Sixteen @entity1 (32%) reported a history of previous recurrent attacks, of whom seven had a history of previous treatments. The main cause of @entity3327 was idiopathic or intracavernosal injection with @entity3302 . All @entity1 were initially treated by corporal blood aspiration and injection with @entity6358 ; if this failed or if the @entity3327 was prolonged (> 48 h) various shunts were used. The hospital stay was significantly shorter among @entity1 with @entity3302 -induced or brief @entity3327 . In the long-term follow-up of 35 @entity1 (mean 66.4 months, range 3-220) only 15 (43%) reported preserved erectile function, and this was more likely in @entity1 with brief @entity3327 (< 48 h). Eight @entity1 (23%) reported subsequent recurrent attacks of @entity3327 ; all were managed successfully as they presented shortly after their onset. @entity82 was detected in 20 @entity1 (57%), and was significantly more common in those with prolonged @entity3327 (> 48 h) or from causes other than @entity3302 . The 20 @entity323 @entity1 evaluated by Doppler ultrasonography had severe echo-dense @entity82 and high end-diastolic velocities suggesting @entity5501 in all except two. In five @entity1 with shunts cavernosography showed extensive @entity1211 irrespective of site of the shunt. MRI in five @entity1 with @entity82 showed heterogeneous areas of low signal intensity, corresponding with @entity527 and @entity82 . On univariate analysis the final result of management (complete detumescence or not), the duration of @entity3327 and the presence of @entity82 significantly influenced erectile function. On multivariate logistic regression only the first remained significant. CONCLUSIONS: @entity258 for > 48 h, failure to maintain complete detumescence after management, and marked @entity82 during the follow-up are the most significant risk factors responsible for @entity323 , with failure to achieve complete detumescence the most detrimental.
